Meta Hunter's 3D NLS study will be a new way to monitor the bladder

Meta Hunter's 3D NLS study will be a new way to monitor the bladder

Malignant bladder tumors account for the 8th in male patients and the 18th in female patients in the tumor disease structure. In terms of absolute growth rate, bladder cancer ranks fourth among tumor diseases (the top three are: prostate cancer, kidney cancer and testicular cancer). Multiple and frequent recurrences are characteristic of bladder tumors.

In all countries, bladder tumors were morphologically transient cell carcinomas in most cases (90-95%); the remaining cases were associated with squamous cell carcinomas and adenocarcinomas. Non-epithelial tumors account for less than 1%.

In recent years, computed tomography, magnetic resonance tomography, and transurethral ultrasonography have primarily been used as corrective diagnostic methods to determine the depth of bladder tumor invasion. Based on information provided by Nesterova V. and others, a recent approach to 3D NLS studies using Meta Hunter may become critical in specifying bladder cancer prevalence and conducting case surveillance. The advantages of this method, including its availability, painlessness, and lack of radiation exposure, allow for multiple studies to be performed while monitoring cases.